The PEX Research Department is a specialised team with extensive experience in the healthcare market, which uses unique, proprietary research methods. The research we carry out is based on close collaboration with scientific centres.

Our mission is to deliver projects that fully meet our clients’ needs. By combining our research, analytical and consulting expertise, we are able to provide comprehensive solutions that bring real benefits to the healthcare sector.

The research team focuses on innovative approaches and continuous development to provide our clients with the highest quality research and consultancy services.

The ECONOMEDICA study is a unique project based on the analysis of patient data and clinicians’ opinions. Its main objective is to collect comprehensive epidemiological, medical and cost information on specific conditions in Poland.

Its distinctive feature is an extensive quantitative market study that illustrates the numbers and flows of patients with specific clinical parameters in the healthcare system. The study has broad applications, including in the area of Market Access, enabling the size of target groups of therapies under different reimbursement options to be determined. Additionally, it provides data for calculating the cost-effectiveness of new therapies.

The data collected in the ECONOMEDICA survey are also important for planning marketing activities. They allow the size of target groups to be identified, patient flows to be analysed and current diagnostic and therapeutic regimes to be assessed.

Examples of research topics pursued at PEX:

  • EXPLORATORY RESEARCH (recognition of the market in a given area) e.g.: before launching a new product, in a situation of market change -> who is treating, where are my patients, how do I treat – regimens used, criteria for choosing therapies, what is important in a given area, with whom am I competing, how is my organisation perceived, etc.?
  • PATIENTS’ PATIENT FLOW (patient flow) -> how patients who could use my product flow through the system,
  • USED THERAPEUTIC SCHEMES -> current therapies used, patients’ treatment history [where my drug is, what treatment is being used with currently available treatment options, what will change when new molecules come in,
  • PATIENT PROFILE -> who is the target for my medicine, in which patients do doctors use my medicine, how can I enlarge the target,
  • IDENTIFICATION OF BARRIERS -> e.g.: affecting the restriction of use of my drug, restriction of inclusion in the drug programme, limited number of patients in centres with PL,
  • EPIDEMIOLOGICAL RESEARCH -> population data, medical data, dedicated to MarketAccess activities,
    Research for the CALCULATION of indirect and direct costs incurred by patients due to illness,
  • Research for the CALCULATION of indirect and direct costs incurred by patients due to illness,
  • RESEARCH WITH PATIENTS -> description of the disease through the eyes of the patient, social aspect of living with the disease concerning patients and their families,
  • PRODUCER PERCEPTION -> how I am perceived vs. competitor companies/products, with which attributes I am associated and with which I am not,

The SPFF report provides a comprehensive diagnostic tool for pharmaceutical companies to benchmark company performance against market benchmarks. It focuses on analysing the soft elements of team health, such as satisfaction, loyalty and job satisfaction, as well as assessing representatives’ working tools. Takes a deeper analysis, examining the pharmaceutical industry’s adaptation to changing customer expectations.

Through the results, pharmaceutical companies can obtain detailed information on the effectiveness of their team and the extent to which they are aligned with current trends and market needs, enabling them to make more informed business decisions and growth strategies.

Research into the diagnostic and therapeutic habits of doctors in a particular therapeutic area, brand image research. In this study:

  • we use quantitative methods to gather the opinions and declarations of respondents. This provides us with clear figures that allow us to identify trends, preferences and consumer behaviour,
  • we combine the marketing aspect with a clinical approach, using a collection of facts from patient records. This perspective allows us to better understand the social, psychological and behavioural context of our target groups,
  • Our approach also uses projective techniques, typical of qualitative research. These advanced methods allow us to probe into the hidden motivations and needs of doctors, which is crucial for effective marketing strategies.


Scroll to Top